Waiting for the Earnings Onslaught

 | Jan 19, 2012 | 2:48 PM EST  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

hgsi

The indices continue to hold up well as we await the onslaught of major earnings reports tonight. There is a bit of a divergence developing, as I'm seeing a fair amount of profit-taking in select small-caps while financials and old tech exhibit relative strength.

I suspect there are some bears itching to be more aggressive with shorts, but they are holding off until the earnings news hits tonight. With a market that is technically extended and with expectations fairly high, the likelihood of selling increases.

I've been a heavy net seller today, and I took a number of stocks off my screen. It has been a good run and with things starting to tire, I'm happy to retreat into more cash and wait for things to develop

One buy I made this afternoon is Human Genome Sciences (HGSI), which received a recommendation and a $14 price target this morning from Maxim Group. I like how it is turning up off recent lows and will start accumulating a little.

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.